Literature DB >> 33248483

First-line treatment for type 2 diabetes: is it too early to abandon metformin?

Francesco Zaccardi1, Kamlesh Khunti2, Nikolaus Marx3, Melanie J Davies4.   

Abstract

Entities:  

Year:  2020        PMID： 33248483     DOI： 10.1016/S0140-6736(20)32523-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Changing the diabetes treatment paradigm from glucose control to cardiorenal protection.

Authors:  Preethika Ekanayake; Sunder Mudaliar
Journal:  Indian J Med Res       Date:  2021-05       Impact factor: 5.274

2.  Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data.

Authors:  Peter N Taylor; Qi Zhuang Siah; Omar Marei; Mia McDade-Kumar; Nasser Rachedi; Robert Bracchi; Richard Boldero; Kath Haines; Mohammed Alhadj Ali; Robert French; Colin M Dayan
Journal:  Diabet Med       Date:  2022-07-19       Impact factor: 4.213

3.  Geographic variation in and contextual factors related to biguanide adherence amongst medicaid enrolees with type 2 Diabetes Mellitus.

Authors:  Vincent Learnihan; Ralf-D Schroers; Philip Coote; Marcus Blake; Neil T Coffee; Mark Daniel
Journal:  SSM Popul Health       Date:  2021-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.